Back to results
US 10,377,756 B2Granted
18F-labelled folates
AssigneeMerck & Cie
InventorsSimon Mensah Ametamey, Rudolf Moser, Tobias Ludwig Ross, Phoebe Lam, Viola Groehn
Life of this patent
Estimating the term…
Abstract
The present invention is directed towards a new method of synthesis of 18F-folate radiopharmaceuticals, wherein fluorine-18 is attached to a pteroate (or folate) or derivative thereof, through direct radiolabeling with 18[F]fluoride, as well as 18F-folate radiopharmaceuticals obtained by such method of synthesis and their use in diagnosis and monitoring of cancer therapy and therapy of inflammatory and autoimmune diseases.
Claims14
A method of direct radiolabeling of the glutamate moiety of a folate compound with 18F comprising:
- reacting a compound of formulae VII or VIIa with 18F,
- wherein
- X1 to X5 are N,
- X6, X7 are independently of each other O or NH,
- R1, R2 are independently of each other H, Hal, —OR′, —NHR′, C1-C12 alkyl, C1-C12 alkoxy, C1-C12 alkanoyl, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C12 alkoxy)carbonyl, or (C1-C12 alkylamino)carbonyl,
- R′ is H or C1-C6 alkyl,
- R3, R4 are independently of each other H, formyl, iminomethyl, nitroso, C1-C12 alkyl, C1-C12 alkoxy, C1-C12 alkanoyl, or halosubstituted C1-C12 alkanoyl,
- R5 is H, CN, Hal, NO2, C1-C12 alkyl, C1-C12 alkoxy, C1-C12 alkanoyl, C2-C12 alkenyl, C2-C12 alkynyl, (C1-C12 alkoxy)carbonyl, or (C1-C12 alkylamino)carbonyl,
- R6, R7 are independently of each other H or straight chain or branched C1-C12 alkyl, which is unsubstituted or substituted by at least one CN, Hal, or NO2,
- S2 is straight chain or branched C1-C6 alkyl, which is unsubstituted or substituted by at least one CN, Hal, or NO2,
- m is 1,
- p is 0, 1 or 2,
- q has a value of 1 to 7,
- Z is a leaving group, and
- wherein 18F is activated by phase transfer catalyst in combination with potassium carbonate or oxalate,
- to obtain a 18F-labeled compound of formulae VI or VIa,
13 more elements
Dependencies are inferred from the claim text.